215 related articles for article (PubMed ID: 30917869)
1. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.
Elliott J; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Syst Rev; 2019 Mar; 8(1):75. PubMed ID: 30917869
[TBL] [Abstract][Full Text] [Related]
2. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Cannabis for pediatric epilepsy: protocol for a living systematic review.
Elliott J; DeJean D; Clifford T; Coyle D; Potter B; Skidmore B; Alexander C; Repetski AE; McCoy B; Wells GA
Syst Rev; 2018 Jul; 7(1):95. PubMed ID: 30021618
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review.
Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F
Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of epilepsy surgery in children and adolescents with drug resistant focal epilepsy at three years in a tertiary care epilepsy center in Thailand.
Anurat K; Khongkhatithum C; Pattanaprateep O; Chamroonrat W; Boongird A; Visudtibhan A; Thampratankul L
J Clin Neurosci; 2020 Sep; 79():163-168. PubMed ID: 33070889
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of economic evaluations of treatments for patients with epilepsy.
Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA
Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
Zueger PM; Schultz NM; Lee TA
Pharmacoeconomics; 2014 Nov; 32(11):1079-91. PubMed ID: 25052903
[TBL] [Abstract][Full Text] [Related]
13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluations of nonpharmacological treatments for drug-resistant epilepsy: A systematic review.
Chan HY; Janssen LMM; Wijnen BFM; Hiligsmann M; Majoie MHJM; Evers SMAA
Epilepsia; 2023 Nov; 64(11):2861-2877. PubMed ID: 37545415
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses.
Wang Y; Camateros P; Smith D; Dawe D; Ellis P
Syst Rev; 2019 Jun; 8(1):139. PubMed ID: 31186068
[TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
18. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
20. Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy.
Widjaja E; Papastavros T; Sander B; Snead C; Pechlivanoglou P
PLoS One; 2019; 14(11):e0224571. PubMed ID: 31747402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
